| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/09/2005 | EP1511512A1 Novel uses of parapoxvirus preparations |
| 03/09/2005 | EP1511502A2 Probiotic therapies using lactobacillus reuteri |
| 03/09/2005 | EP1511499A2 Immunomodulatory compounds and methods of use thereof |
| 03/09/2005 | EP1511497A1 Treatment of post-menopausal complaints in breast cancer patients which comprises tibolone and a serm |
| 03/09/2005 | EP1511496A1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein |
| 03/09/2005 | EP1511492A2 Protease inhibitors |
| 03/09/2005 | EP1511491A1 Derivatives of azepine and thiazepan as interleukin converting enzyme inhibitors |
| 03/09/2005 | EP1511488A2 Human adam-10 inhibitors |
| 03/09/2005 | EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound |
| 03/09/2005 | EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
| 03/09/2005 | EP1272499B1 Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 03/09/2005 | EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases |
| 03/09/2005 | EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 03/09/2005 | CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 03/09/2005 | CN1592746A LFA-1 antagonist compounds |
| 03/09/2005 | CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination |
| 03/09/2005 | CN1592635A Autologous growth factor cocktail composition, method of production and use |
| 03/09/2005 | CN1592576A Disruption of the prostaglandin E synthase 2 gene |
| 03/09/2005 | CN1590408A Preparation technology of globe fish peptide and its medical health care use |
| 03/09/2005 | CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 03/09/2005 | CN1589905A Medical composition for treating desmosis and its use |
| 03/09/2005 | CN1589900A Medical health protection use of globe fish glue |
| 03/09/2005 | CN1589883A Oral cavity disintegration tablet for treating gout and its preparation method |
| 03/09/2005 | CN1589882A Medicine for treating rheumatoid anthritis and its preparation method |
| 03/09/2005 | CN1589870A Incised wound medicine |
| 03/09/2005 | CN1589859A Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis |
| 03/09/2005 | CN1589842A Mistura and its preparation method |
| 03/09/2005 | CN1589837A Traditional Chinese medicine for treating spondylitis |
| 03/09/2005 | CN1589828A Compound saffron oil and its production technology |
| 03/09/2005 | CN1589786A Composite effervescent preparation containing soya isoflavone |
| 03/09/2005 | CN1589784A 5-hydroxymethyl -2-furol and its derivative analogue medical use |
| 03/09/2005 | CN1192021C 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
| 03/09/2005 | CN1191861C Medicinal compositions containing anti-Fas antibody |
| 03/09/2005 | CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 03/09/2005 | CN1191838C Medicine powder in bag for curing rheumatism and osteoproliferation |
| 03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/08/2005 | US6864228 Use of bisphosphonates for the treatment of osteogenesis imperfecta |
| 03/08/2005 | US6863901 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 03/08/2005 | US6863693 Phospholipid-coated implants |
| 03/08/2005 | US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 03/08/2005 | CA2480712A1 Chondrocyte therapeutic delivery system |
| 03/08/2005 | CA2351848C Method for increasing pet activity |
| 03/03/2005 | WO2005019465A1 Sugar chain-cutting agent |
| 03/03/2005 | WO2005019245A1 Heptadepsin |
| 03/03/2005 | WO2005019161A1 Cathepsin cysteine protease inhibitors |
| 03/03/2005 | WO2005018675A1 Therapeutic agent for autoimmune disease |
| 03/03/2005 | WO2005018648A1 (20S)-1α-HYDROXY-2-METHYLENE-19-NOR-VITAMIN D3 AND ITS USES |
| 03/03/2005 | WO2005018630A1 Omega-3 fatty acids for the treatment of canine ostheoarthritis |
| 03/03/2005 | WO2005018627A1 Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050050589 Soya cell strains with high isoflavone content |
| 03/03/2005 | US20050049413 Quinoline derivatives |
| 03/03/2005 | US20050049312 N-(1-adamantyl)alkyl]alkano-amidines, guanidines or N'-nitroguanidines; non-competitive receptor antagonists for the NMDA receptor |
| 03/03/2005 | US20050049303 Adamantane derivatives |
| 03/03/2005 | US20050049294 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 03/03/2005 | US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 03/03/2005 | US20050049251 Inhibitors of p38 |
| 03/03/2005 | US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine |
| 03/03/2005 | US20050049241 Vanilloid receptor antagonists; acute or chronic pain, itching; inflammation; gastrointestinal and urinary tract disorders; tracheobronchial and diaphragmatic dysfunction |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/03/2005 | US20050049216 Immunostimulatory nucleic acid molecules |
| 03/03/2005 | US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex |
| 03/03/2005 | US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides |
| 03/03/2005 | US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis |
| 03/03/2005 | US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048135 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 03/03/2005 | US20050048058 Antibody against fibroblast growth factor-23 |
| 03/03/2005 | US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke |
| 03/03/2005 | US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 03/03/2005 | US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine |
| 03/03/2005 | US20050048026 Remedies for ischemic diseases |
| 03/03/2005 | US20050047958 Methods for sterilizing preparations of digestive enzymes |
| 03/03/2005 | CA2536764A1 .alpha.-aminoamide derivatives useful as anti-inflammatory agents |
| 03/03/2005 | CA2535359A1 Cathepsin cysteine protease inhibitors |
| 03/02/2005 | EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives |
| 03/02/2005 | EP1510518A2 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels |
| 03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
| 03/02/2005 | EP1510210A1 Immunity-related protein kinase inhibitors |
| 03/02/2005 | EP1510137A1 Pyruvate enriched onion extract |
| 03/02/2005 | EP1509621A1 Treatment with cytokines for alzheimer's disease |
| 03/02/2005 | EP1509618A2 Autoimmune conditions and nadph oxidase defects |
| 03/02/2005 | EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 03/02/2005 | EP1509612A2 Transcellular drug delivery system |
| 03/02/2005 | EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509518A1 Calcium receptor modulating agents |
| 03/02/2005 | EP1509515A2 Substituted 4-aryl-4h-pyrrolo 2,3-h chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509499A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |